Alfusin T 2.5 Tablet ER is a prescription medicine used to treat benign prostatic hyperplasia (BPH)—a non-cancerous enlargement of the prostate gland in men. This condition causes urinary symptoms such as difficulty in starting urination, weak urine flow, frequent urination, and the urge to urinate at night. The medicine is a combination of Alfuzosin and Tadalafil, two agents that work through different mechanisms to relieve symptoms and improve urinary function.
Alfuzosin is an alpha-adrenergic blocker that relaxes the smooth muscles in the bladder neck and prostate, allowing urine to pass more easily. Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor, enhances smooth muscle relaxation and blood flow in the prostate and bladder area, improving urinary symptoms associated with BPH.
Uses
- Treatment of Benign prostatic hyperplasia
Benefits of Alfusin T 2.5
- Relieves urinary symptoms caused by benign prostatic hyperplasia (BPH)
- Improves urine flow and reduces difficulty in urination
- Decreases frequency and urgency of urination
- Reduces nighttime urination (nocturia)
- Enhances bladder emptying and comfort
- May also improve erectile function due to tadalafil’s vasodilatory effect
How Alfusin T 2.5 Tablet works
Alfusin T 2.5 Tablet ER combines two complementary mechanisms:
- Alfuzosin, an alpha-1 adrenergic blocker, works by relaxing the smooth muscles around the prostate gland and bladder neck. This action decreases urinary resistance, making it easier to pass urine and reducing the urge and frequency of urination.
- Tadalafil, a PDE5 inhibitor, improves smooth muscle relaxation by increasing cyclic guanosine monophosphate (cGMP) levels. This effect enhances urinary flow and may relieve pressure in the bladder outlet area.
Together, these agents provide rapid relief from urinary obstruction, improve urinary comfort, and enhance overall quality of life in men with BPH.
Side effects
- Headache
- Dizziness or light-headedness
- Fatigue or weakness
- Nasal congestion
- Upper respiratory tract infection
